Patients Coming Off Anti-Obesity Jabs Regain Pounds at a Quadrupled Rate Than Those on Conventional Diets

New research suggests that individuals who discontinue blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.

Findings released in a major medical journal shows that while obese individuals frequently drop about a fifth of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month after stopping.

"Users buying such treatments should be aware of the danger of quick weight regain when the therapy ends," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to pre-treatment mass in about a year and a half.

Comparing Therapies

The analysis, which examined dozens of trials involving thousands of participants, contrasted the results of the injectable medications with other pills.

Scientists emphasize that individuals who shed pounds through dieting generally see a less rapid weight regain—approximately 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Nutrition scientists believe the mechanism of the drugs is key to understanding the accelerated weight return.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone levels far above than the body's typical production may cause the body to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely."

An Ongoing Condition?

Health authorities recommend the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.

A number of clinicians say that, considering the likelihood of weight regain, the therapy might need to be long-term.

This opinion is echoed by pharmaceutical companies, who note that the findings "emphasize the persistent character of obesity," akin to managing conditions like hypertension.

User Accounts

Individuals who have stopped the jabs explain a sudden return of appetite.

"It was like something activating and I was suddenly starving," described one woman.

This difficulty is compounded if patients have not adopted lasting dietary or behavioural modifications during therapy.

Widespread Adoption

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.

• Adoption is greater among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, experts emphasize that while the jabs are effective tools for weight loss, they are not a magic cure and long-term success relies on combined behavioural management.